Results 81 to 90 of about 8,222 (211)

Erectile dysfunction in dermatology and venereology: From aetiopathogenic mechanisms to practical considerations for dermato‐venereologists

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 39, Issue 10, Page 1725-1737, October 2025.
Multiple inflammatory, infectious and autoimmune dermato‐venereological conditions are associated with erectile dysfunction (ED) due to underlying intricate vasculogenic, neurogenic, endocrine and psychogenic mechanisms. It is recommended that practitioners screen dermatology patients for ED and associated comorbidities, provide personalized lifestyle ...
Andrei Tanasov, George‐Sorin Tiplica
wiley   +1 more source

Food supplements adulteration with undeclared synthetic phosphodiesterase type-5 drugs (PDE-5) inhibitors [PDF]

open access: yes, 2014
The use ofplant food supplements (PFS) in developed countries is becoming increasingly popular mostly due to the consumers' widespread idea that natural products are safer and healthier than conventional pharmaceutical drugs [l].
Amaral, Joana S.   +2 more
core   +1 more source

Tadalafil improves lean mass and endothelial function in nonobese men with mild ED/LUTS: in vivo and in vitro characterization [PDF]

open access: yes, 2017
PURPOSE: Phosphodiesterase type-5 inhibitor administration in diabetic men with erectile dysfunction (ED) is associated with reduced waist circumference.
Aversa, Antonio   +8 more
core   +1 more source

Inibidores da 5-fosfodiesterase no tratamento sintomático da hiperplasia benigna da próstata [PDF]

open access: yes, 2011
Trabalho final de mestrado integrado em Medicina, área científica de Urologia, apresentado á Faculdade de Medicina da Universidade de CoimbraTanto a hiperplasia benigna da próstata como a disfunção eréctil são patologias com elevada prevalência em ...
Costa, Christine Silva
core  

EYE‐CODE Protocol for the Nonophthalmologist for Treatment of Retinal Artery Occlusion After Intra‐Arterial Injection of Soft‐Tissue Fillers: 2025 Update

open access: yesJournal of Cosmetic Dermatology, Volume 24, Issue 7, July 2025.
ABSTRACT Background Vision loss following a facial esthetic procedure with soft‐tissue fillers is an event for which there is only a short treatment window to restore blood flow before irreversible ischemic damage occurs. Objective To provide a current standardized treatment approach for the management of retinal artery occlusion after intra‐arterial ...
Sheila Barbarino   +2 more
wiley   +1 more source

Safety, Tolerability, and Pharmacokinetics of RT234 (Vardenafil Inhalation Powder): A First-in-Human, Ascending Single- and Multiple-Dose Study in Healthy Subjects

open access: yesJournal of Aerosol Medicine, 2020
Background: RT234 (vardenafil inhalation powder) is being developed for pulmonary administration “as needed”, to acutely improve exercise tolerance and symptoms in patients with pulmonary arterial hypertension (PAH).
M. Eldon   +5 more
semanticscholar   +1 more source

Unraveling the Causal Association Between Circulating Copper Levels and Erectile Dysfunction: A Comprehensive Analysis via Bidirectional Two Sample Mendelian Randomization Study

open access: yesFood Science &Nutrition, Volume 13, Issue 6, June 2025.
Erectile dysfunction (ED) is a common and debilitating condition that negatively impacts men's quality of life and psychological well‐being. Excessive circulating copper levels are causally linked to an increased risk of ED, as shown by Mendelian randomization and meta‐analysis. Balanced copper intake is crucial for sexual health, highlighting the need
Zilong Wang   +6 more
wiley   +1 more source

Long-term cardioprotection with phosphodiesterase-5 inhibition against ischemia-reperfusion injury: Role of nitric oxide. [PDF]

open access: yes, 2005
Recent studies have shown that the potent phosphodiesterase-5 (PDE-5) inhibitor, sildenafil citrate, induces a powerful cardioprotective effect against ischemia-reperfusion (I/R) injury in rabbit and mouse hearts.
Daoud, Vladimir Paul
core   +1 more source

Current pharmacological agents for the treatment of premature ejaculation [PDF]

open access: yes, 2014
This study was aimed to review and assess the update studies regarding medical treatment for premature ejaculation (PE). It is the most common sexual problem affecting men. It can affect men at all ages and has a serious impact on the quality of life for
Okan Baş, Onur Dede, Şahin Bağbancı
core   +1 more source

Intracavernosal platelet‐rich plasma therapy for erectile dysfunction: Current evidence and future directions

open access: yesUroPrecision, Volume 3, Issue 2, Page 99-106, June 2025.
Abstract Erectile dysfunction (ED) is the inability to achieve or maintain an erection sufficient for satisfactory sexual performance, affecting over 50% of men aged 50 and older. ED is often linked to lifestyle factors and comorbidities, such as diabetes and cardiovascular disease.
Ahmed Ragheb
wiley   +1 more source

Home - About - Disclaimer - Privacy